Page last updated: 2024-09-03

3-(2,4-dimethoxybenzylidene)anabaseine and Alloxan Diabetes

3-(2,4-dimethoxybenzylidene)anabaseine has been researched along with Alloxan Diabetes in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdelrazek, HM; Moustafa, YM; Youssef, ME1

Other Studies

1 other study(ies) available for 3-(2,4-dimethoxybenzylidene)anabaseine and Alloxan Diabetes

ArticleYear
Cardioprotective role of GTS-21 by attenuating the TLR4/NF-κB pathway in streptozotocin-induced diabetic cardiomyopathy in rats.
    Naunyn-Schmiedeberg's archives of pharmacology, 2021, Volume: 394, Issue:1

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Benzylidene Compounds; Cardiotonic Agents; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Interleukin-6; Male; Myeloid Differentiation Factor 88; Myocardium; NF-kappa B; Nicotinic Agonists; Proto-Oncogene Proteins c-akt; Pyridines; Rats, Wistar; Signal Transduction; Streptozocin; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Troponin T; Tumor Necrosis Factor-alpha

2021